CurrentAmeriHealthPolicy N/A

CNS Stimulants High Cumulative Dose Prior Authorization Request Form

A prior authorization request form to document clinical and administrative information when requesting approval for CNS stimulant prescriptions that exceed high cumulative dose limits, including patient, provider, medication, diagnosis, counseling, and quantity-limit information required for review by the Pharmacy Benefit Manager.

Policy Summary

PayerAmeriHealth

PolicyCNS Stimulants High Cumulative Dose Prior Authorization Request Form

Policy CodePolicy N/A

Change TypeAdministrative form (no material changes)

Effective Date

Next Review Date

Key ActionProvider must complete and submit this CNS Stimulants High Cumulative Dose Prior Authorization Request Form with all required member, provider, medication, diagnosis, and clinical justification fields; request may be denied unless all required information is received.

SourceLink

POLICY UPDATE CHANGES

No material clinical/coverage changes

FormDocument Type

ConditionalCoverage Type

Form purpose and scope

This is an administrative prior authorization request form used by the Pharmacy Benefit Manager to evaluate requests for CNS stimulant doses that exceed plan high cumulative dose limits. The form is used to collect required clinical and administrative information to support review by the PBM.

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

The form collects: member and provider identifiers (Member Name; Provider Name; Insurance ID#; NPI#; Specialty; Provider address/phone/fax; Member Date of Birth), medication details (Medication Name; Strength; Dosage Form; Directions for Use; indication if generic substitution acceptable; whether the request is for continuation of therapy), clinical diagnosis and ICD-10 code(s), counseling documentation (assessment and counseling on substance abuse, cardiac-related adverse events, and new or worsening psychosis), and justification for non-standard dosing or quantity limits (high cumulative dose justification, quantity requested per day, whether requested dose is commercially available, patient-specific limitations such as inability to swallow larger pills, malabsorption, or feeding tube, and medical necessity specification).

CNS Stimulants High Cumulative Dose PA Form - Metadata

Policy TitleCNS Stimulants High Cumulative Dose Prior Authorization Request Form

PayerAmeriHealth

Document TypeForm-based prior authorization

Coverage TypeConditional

Policy NumberN/A

Effective Date

Key ActionA prior authorization request form to document clinical and administrative information when requesting approval for CNS stimulant prescriptions that exceed high cumulative dose limits, including patient, provider, medication, diagnosis, counseling, and quantity-limit information required for review by the Pharmacy Benefit Manager.

High cumulative dose authorization criteria (form fields)

High Cumulative Dose Authorization Criteria (form fields)

Request may be reviewed/denied unless all required information is received. Provider must document the following items:

Provider and member information: Provider and member identifying information completed (Member Name; Provider Name; Insurance ID#; NPI#; Specialty; Provider address/phone/fax; Member Date of Birth)
Medication information completed (Medication Name; Strength; Dosage Form; Directions for Use; indication if generic substitution acceptable; indicate if continuation of therapy)
Clinical diagnosis and ICD-10: Clinical diagnosis selected and ICD-10 code(s) provided (e.g., Attention deficit hyperactivity disorder (ADHD) or other diagnosis with ICD-10 code(s))
High cumulative dose justification: document inadequate response or intolerance to an alternative active ingredient within the CNS stimulant class when attempting to increase dose beyond cumulative high dose limit, or note 'No prior' if applicable
Form includes explicit question: 'Has the patient had an inadequate response or inability to tolerate an alternative active ingredient within the CNS stimulant drug class to increasing the dose beyond the cumulative high dose limit? 0No prior'
Prescriber assessment and counseling documented for risks: substance abuse, cardiac-related adverse events (e.g., hypertension), and new or worsening psychosis (e.g., manic behavior)
Quantity-limit request details: quantity requested per DAY provided
Commercial availability / patient-specific limitations: Documentation whether requested dose can be reached using higher strengths of commercially available dosage forms or whether there are patient-specific limitations (e.g., inability to swallow larger pills, malabsorption, feeding tube)
Requested dose commercially available: Indicate whether the requested dose is commercially available (Yes/No)
Medical necessity: Documentation that the requested dose is medically necessary (Yes/No). If yes, provide specification.
Optional comments: Optional: Other comments, diagnoses, symptoms, medications tried/failed, or other clinically relevant information

Required provider actions and documentation

Prior Authorization

Submit completed prior authorization form

Provider must complete and submit this CNS Stimulants High Cumulative Dose Prior Authorization Request Form with all required member, provider, medication, diagnosis, and clinical justification fields; request may be denied unless all required information is received.

Documentation Required

Document counseling on risks

Provider must document that the patient was assessed and counseled regarding risk for substance abuse, cardiac-related adverse events (e.g., hypertension), and risk for new or worsening psychosis (e.g., manic behavior).

Documentation Required

Provide dose justification

For requests exceeding cumulative high dose limits, provider must document inadequate response or intolerance to alternative active ingredients within the CNS stimulant class and whether requested dose is commercially available or cannot be achieved due to patient-specific factors (e.g., inability to swallow larger pills, malabsorption, feeding tube); also indicate if the requested dose is medically necessary.

Request may be reviewed or denied unless all required information is received; providers must complete and submit the CNS Stimulants High Cumulative Dose Prior Authorization Request Form with all required member, provider, medication, diagnosis, and clinical justification fields, and incomplete submissions risk denial.

Definitions

High cumulative dose: Dose exceeding the payer's established cumulative limit for CNS stimulant medications (specific numeric limits not included on form).

Numeric cumulative dose limits are established by the payer and are not specified on this form; the form does capture patient-specific limitations that may prevent achieving a requested dose with standard products (for example, inability to swallow larger pills, malabsorption, or presence of a feeding tube).

Policy Summary

PayerAmeriHealth

PolicyCNS Stimulants High Cumulative Dose Prior Authorization Request Form

Policy CodePolicy N/A

Change TypeAdministrative form (no material changes)

Effective Date

Next Review Date

SourceLink

On This Page

OpenPayer

CNS Stimulants High Cumulative Dose Prior Authorization Request Form

Form purpose and scope

High cumulative dose authorization criteria (form fields)

Diagnosis codes

Required provider actions and documentation

Definitions

Document changes and review dates